11 unknown. 11 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Unknown 11 |
| Phase 2 | 3 | Unknown 3 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis Tofacitinib 5 MG, Prednisolone, Placebo of tofacitinib 5mg - Takayasu Arteritis | Phase 3 | Unknown | Chinese SLE Treatment And Research Group | 50 | 2023-01-20 | 2023-03-01 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Drug-eluting Balloon for Treatment of Non-atherosclerotic Renal Artery Stenosis Angioplasty with paclitaxel eluting balloon, Angioplasty with plain old balloon - Hypertension, Renovascular | Phase 3 | Unknown | Peking Union Medical College Hospital | 90 | 2019-10-01 | 2020-04-29 |
| Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis Rituximab, endoxan, Methylprednisolone - ANCA Associated Vasculitis | Phase 3 | Unknown | Leiden University Medical Center | 100 | 2019-05-03 | 2023-12-14 |
| The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children Ibuprofen, Prednisone, Methotrexate - Vasculitis | Phase 3 | Unknown | Assiut University | 70 | 2018-11-11 | 2021-02-15 |
| Anti-inflammatory Treatment for Inactive Takayasu Arteritis Prednisone, cyclophosphamide - Takayasu Arteritis, Anti-Inflammatory Agents | Phase 2 / Phase 3 | Unknown | Chinese Academy of Medical Sciences, Fuwai Hospital | 40 | 2018-06-01 | 2018-06-08 |
| The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach 5 mg prednisone, 0 mg prednisone - Granulomatosis With Polyangiitis, Wegener Granulomatosis | Phase 3 | Unknown | University of South Florida | 12 | 2014-02-17 | 2024-07-29 |
| A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study) Prednisolone, immunoglobulin - Kawasaki Disease, Steroid | Phase 3 | Unknown | National Taiwan University Hospital | 100 | 2013-10-17 | 2017-06-27 |
| Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AF Amiodarone - Atrial Fibrillation | Phase 3 | Unknown | Western Galilee Hospital-Nahariya | 104 | 2013-05-01 | 2013-03-25 |
| Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change Extending peripheral intravenous (IV) cannula dwell times - Phlebitis | Phase 2 / Phase 3 | Unknown | Royal Brisbane and Women's Hospital | 200 | 2004-03-01 | 2005-06-24 |
| WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides Azathioprine: 2 mg/kg/day, methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week - Systemic Wegener's Granulomatosis | Phase 3 | Unknown | Hospices Civils de Lyon | 126 | 1999-01-01 | 2007-10-10 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3) · Takayasu Arteritis (3) · Granulomatosis with Polyangiitis (2) · Phlebitis (2) · Systemic Vasculitis (2) · Arthritis, Rheumatoid (1) · Atrial Fibrillation (1) · Cardiovascular Diseases (1) · Fibromuscular Dysplasia (1) · Hypertension, Renovascular (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1)
Cardiovascular Diseases (10) · Vascular Diseases (10) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Skin Diseases, Vascular (7) · Autoimmune Diseases (4) · Immune System Diseases (4) · Aortic Arch Syndromes (3) · Aortic Diseases (3) · Arteritis (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2)
Prednisolone (3) · Prednisone (3) · Cyclophosphamide (2) · Methotrexate (2) · Adrenal Cortex Hormones (1) · Amiodarone (1) · Angioplasty (1) · Azathioprine (1) · COVID-19 Vaccines (1) · Glucocorticoids (1) · Ibuprofen (1) · Immunoglobulins (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Rituximab (1)
Assiut University (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Chinese SLE Treatment And Research Group (1) · Hospices Civils de Lyon (1) · Leiden University Medical Center (1) · National Taiwan University Hospital (1) · Paul R Fortin (1) · Peking Union Medical College Hospital (1) · Royal Brisbane and Women's Hospital (1) · University of South Florida (1) · Western Galilee Hospital-Nahariya (1)
China (2) · Australia (1) · Canada (1) · Egypt (1) · France (1) · Israel (1) · Netherlands (1) · Taiwan (1) · United States (1)
Atar Shaul, MD (1) · Jeffrey P Krischer, PhD (1) · Lilach Shema-didi, PhD (1) · Mei-Hwan Wu, MD, PhD (1) · Ming-Tai Lin, MD, PhD (1) · Nicola Makhoul, MD (1) · Paul R Fortin, MD,MPH,FRCPC (1) · Peter A Merkel, MD, MPH (1) · Safiea AF El-Deeb, PROF (1) · Xinping Tian, MD (1) · Xiongjing Jiang, MD (1) · Yuehong Zheng, MD (1)
PMID 19109574, PMID 28246067, PMID 36130755, PMID 39425055
R01HL115041 (1)